INTRODUCTION {#sec1-1}
============

Erectile dysfunction (ED) is defined as a persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. Epidemiologic studies show that aging is an independent predictor of ED, irrespective of comorbid diseases such as cardiovascular diseases and diabetes.[@ref1][@ref2][@ref3] In addition, prevalence of ED increases progressively with aging.[@ref4][@ref5][@ref6] Since human life expectancy increased enormously in the last century, aging-related ED (A-ED) gained in importance.[@ref7][@ref8] The underlying pathogenetic mechanisms of A-ED, however, are poorly understood. As a result, shortages could be seen in several treatments of A-ED despite many treatment strategies have been developed.[@ref9] Thus, research on the mechanism of A-ED is urgently needed.

MicroRNAs (miRNAs), which generally exist in the eukaryote, are strongly conservative noncoding small RNAs with 19--23nt length. They can regulate gene expression by binding completely or partially to the 3'UTR of target gene related mRNA for posttranscriptional inhibition.[@ref10] It has been proven that miRNAs modulate a variety of functions including proliferation, differentiation, apoptosis, and senescence.[@ref11][@ref12] Importantly, a series of aging-related genes that could be regulated by many miRNAs have been demonstrated to be involved in the pathogenesis of A-ED.[@ref13][@ref14][@ref15] Thus, miRNAs may be involved in the mechanisms of A-ED via regulating various protein functions at the upstream level. In our previous report,[@ref16] we have identified the miRNAs profile in the corpus cavernosum (CC) of rats with A-ED. As a result, up-regulation of miR-200a was identified in the CC of rats with A-ED and its main target pathway was *eNOS/NO/PKG* as the bioinformatic analysis predicted, which had been considered to be one of the important pathways of the physiology of normal erection.

Among the predicted target genes of miR-200a, silent information regulator 1 (SIRT1) is a highly conserved nicotinamide adenine dinucleotide (NAD)+-dependent protein deacetylase and plays important roles in aging, obesity, and cancer.[@ref17][@ref18] It could be deduced that SIRT1 might act as a protected factor in maintaining erectile function because it could up-regulate the endothelial nitric oxide synthase (eNOS) activity, increase the NO production, and promote the endothelium-dependent relaxation.[@ref19][@ref20][@ref21] Our group has previously found that SIRT1 was decreased in the CC of rats with some types of ED. Administration of its activator could ameliorate the erectile function probably by improving endothelial function.[@ref14] Similar to our previous findings,[@ref16] recently miR-200 has been reported by another research to regulate *SIRT*1 through targeting *SIRT*1 3'- UTR.[@ref22] Therefore, it could be hypothesized that miR-200a might be involved in the mechanism of A-ED via regulating the expression of SIRT1, and the most probable target tissue might be endothelial cells.

Based on the above findings, the present study was designed, firstly to testify whether the up-regulated miR-200a was associated with the down-regulated SIRT1, and influenced the endothelial function in the CC of rats with A-ED; secondly, to investigate whether up-regulation of miR-200a in the endothelial cells of CC of aged rats with normal erectile function could lead to the down-regulation of SIRT1 and attenuate the endothelial function, and thus to demonstrate that the miR-200a could contribute to the decrease of erectile function of aged rats to some extent via SIRT1 inhibition and the *eNOS/NO/PKG* pathway influencing. To our knowledge, this is the first study designed to explore the potential role of miR-200 in the development of A-ED, which will provide new perspectives for the researches regarding the underlying mechanism of A-ED.

MATERIALS AND METHODS {#sec1-2}
=====================

 {#sec2-1}

### Animal groups and study design {#sec3-1}

Forty 18-month old male Sprague--Dawley (SD) rats defined as aged rats and eight 3-month SD rats defined as young normal controls (group YN) were used in the present study. All rats underwent apomorphine-induced penile erection test to evaluate the erectile function according to a previously described protocol.[@ref16] Finally, aged rats were divided into two groups: aged rats with normal erectile function (group AN) and aged rats with erectile dysfunction (group AE). Intracavernous pressure (ICP) investigation and histological measurement were applied to further confirm the grouping. After the functional test, all rats were sacrificed, and CCs from different groups were collected for molecular measurements. To testify the potential role of miR-200 in the development of A-ED, the cavernous endothelial cells (CECs) from AN groups were isolated and transfected with miR-200 mimics or negative control. SIRT1 expression and eNOS/NO/PKG pathway were detected after transfection. All procedures were approved by the Institutional Animal Care and Use Committee at Nanjing University.

### In vivo penile erection {#sec3-2}

The apomorphine-induced penile erection test was performed according to the protocol previously described.[@ref16][@ref23] Briefly, apomorphine (Sigma-Aldrich, St. Louis, MO, USA) dissolved in sodium chloride with 0.1% ascorbic acid was injected into the napes of rats at a dosage of 80 μg kg^−1^. Each rat was observed in a transparent cage for 30 min. The latency of the first erection and the number of erections per animal were documented.

### Electrostimulation for penile erection {#sec3-3}

ICP response to electrostimulation of the cavernous nerve (CN) was performed as our groups once described.[@ref24] Briefly, the CNs on both sides were exposed. A 25-gauge needle connected to a PE-50 tube was inserted into the left crura for measurement of ICP. The left carotid artery was subsequently exposed and cannulated with a PE-50 tube to record the mean arterial pressure (MAP). The MAP and ICP were reported by RM6042B/C multichannel signal collection processing system (Chengdu Implement Company, Chengdu, China). Stimulation of CN was performed at a frequency of 15 Hz. with a pulse width of 5 ms, and at 5 V for 60 s with resting periods of 5 min between subsequent stimulations. The highest ICP was chosen for statistical analysis. The ratio of peak ICP/MAP was calculated to evaluate the erectile function.

### Immunohistochemistry staining {#sec3-4}

The histological measurement was performed as reported.[@ref16][@ref24][@ref25] Briefly, the middle penile shafts were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) at 4°C overnight, after which the tissue was transferred to 30% sucrose in PBS at 4°C overnight. The tissue was then embedded and cut transversely at a thickness of 5 μm. The sections were incubated with 3% bovine serum albumin for 30 min at room temperature and then incubated with mouse anti-alpha smooth muscleactin (anti-α-SMA, 1:200, Abcam Inc, Cambridge, Massachusetts) or anti-von Willebrand factor (anti-vWF, 1:200, Abcam Inc, Cambridge, MA, USA) at 4°C overnight, followed by Alexa-488- or Alexa-594-conjugated secondary antibodies (1:500, Invitrogen, Carlsbad, CA, USA). The nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Image analysis was performed by computerized densitometry using Image-Pro Plus 6.0 (Media Cybernetics, Silver Spring, MD, USA). To quantify smooth muscle, the percentage of α-SMA indicating positive area within the CC was analyzed. Similarly, the percentage of vWF indicating positive area was analyzed to quantify the endothelium.

### Isolation of CECs {#sec3-5}

Isolation of CECs was performed according to the protocol as previously described.[@ref26] Briefly, each tissue sample was minced into pieces of about 1 mm^3^, digested in a solution containing 9 ml of 0.1% collagenase II (Invitrogen, Carlsbad, CA, USA) and 1 ml of dispase (Invitrogen) for 30 min at 37°C with vigorous shaking. A volume of 75 μl of 1 mg ml^−1^ DNase I (Sigma-Aldrich, St. Louis, MO, USA) was added for further digestion for 30 min, followed by a 5-min incubation period on ice, and a subsequent addition of 5 ml of Endothelial Growth Medium-2 (EGM2, Lonza Biologics, Portsmouth, NH, USA). The mixture was then filtered through a 100-μm cell strainer (BD Biosciences, Bedford, MA, USA), followed by centrifugation at 400 *g* for 5 min. The cell pellet was washed with PBS, resuspended in 0.5 ml of EGM2, and incubated with anti-CD31 antibody (Abcam, Cambridge, MA, USA) for 45 min at 4°C. The cells were then washed with EGM2 and resuspended in 80 μl of isolation buffer containing 2 mmol l^-1^ EDTA and 0.5% bovine serum albumin in PBS, followed by the addition of 20 μl anti-mouse IgG microbeads (Miltenyi Biotec, Auburn, CA, USA) and incubation at 4°C for 15 min. The cell mixture was then washed and resuspended in 500 μl of isolation buffer, and loaded onto the magnetic column (Miltenyi Biotec) preequilibrated with 3 ml isolation buffer. After washing the column 3 times with 3 ml isolation buffer each time, the target endothelial cells were eluted with 5 ml of isolation buffer. Finally, the target cells were centrifuged and cultured in EGM2 supplemented with 20% fetal bovine serum at 37°C in an atmosphere containing 5% CO~2~.

### Cell transfection {#sec3-6}

As reported,[@ref27][@ref28] the cultured CECs were seeded on six-well plates and were transfected with miR-200a mimics (100 pmol, Genepharma) or mimics negative control RNA (mimics N.C., 100 pmol, Genepharma) using Lipofectamine 2000 (Invitrogen) according to the manufacturer\'s instructions. Cells were harvested 24 h after transfection for Quantitative Real-time PCR (qRT-PCR) and 48 h for protein analysis.

### Western blotting {#sec3-7}

The protein measurement was performed according to our previously described protocol.[@ref14][@ref27] In brief, the tissues stored in liquid nitrogen were powdered and lysed. Then the samples were homogenized in extraction buffer (10.0 mmol l^−1^ Tris pH 7.4, 150.0 mmol l^−1^ sodium chloride, 0.4% TritonX-100 and 1/100 complete protease inhibitors), and centrifuged at 17 000 *g* for 20 min. Thereafter, the protein samples were quantified using a BCA kit (Thermo Scientific, Rockford, IL, USA). Prepared protein samples were separated on 10% SDS-PAGE and transferred onto PVDF Western Blotting Membranes (Roche Diagnostics). The membranes were blocked and then incubated with primary antibodies overnight at 4°C. The final dilutions for primary antibodies were anti-SIRT1 (Abcam, 1:500) and anti-GAPDH (Abcam, 1:1000). Horseradish peroxidase anti-mouse and anti-rabbit (Santa Cruz Biotechnology) were used as secondary antibodies. The signal was detected by the super-signal-enhanced chemiluminescence system (Pierce, Rockford, IL, USA).

### RNA isolation and miRNA qRT-PCR assay {#sec3-8}

As previously reported,[@ref16][@ref27] total RNA of penile tissue samples without urethra and other adventitial tissues was extracted using Trizol reagent (Invitrogen) according to the manufacturer\'s instructions. Glycogen (Invitrogen) was added to the RNA precipitation step. The concentration and quality of the extracted RNA were measured with a spectrophotometer (Eppendorf) at 260 nm and 280 nm (i.e., the A260/A280 ratio). qRT-PCR was performed using a TaqMan PCR kit and the Applied Biosystems 7300 Sequence Detection System. The reactions were incubated in a 96-well optical plate at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. All reactions, including no-template controls, were run in triplicate. After the reactions, the cycle threshold (C~T~) data were determined using default threshold settings, and the mean C~T~ was determined from the duplicate PCRs. A comparative ΔC~T~ method[@ref29] was used to compare each condition with controls, and values are expressed as 2^−ΔCT^. The relative levels of miRNAs in cells and tissues were normalized to U6, a ubiquitously expressed small nuclear RNA.

### Enzyme-linked immunosorbent assay {#sec3-9}

To determine the level of eNOS and cyclic guanosine monophosphate (cGMP) in different groups, we performed the enzyme-linked immunosorbent assay (ELISA) quantitative assay using the rat eNOS and cGMP ELISA kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The experimental conditions were maintained according to the manufacturer\'s protocol.

### Data analysis {#sec3-10}

All data were presented as means ± standard deviation (s.d.). Statistical analysis was determined by the independent Student\'s *t*-test and one-way ANOVA followed by the Turkey-Kramer test for post hoc comparisons using SPSS 16.0 software (SPSS, Chicago, IL, USA). A *P* value cut-off 0.05 was considered as statistically significant.

RESULTS {#sec1-3}
=======
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### The erectile function of rats decrease in the AE group {#sec3-11}

According to the apomorphine test, the experimental animals were divided into different groups. As the results showed, 32 rats in the old group were defined as rats with A-ED. Eight of them were randomly selected for the further experiments and were named as the group of aged rats with ED (group AE). The left 8 aged rats with normal erectile function were included in the group of aged rats with normal erectile function (group AN). Eight 3-month old young rats were used as young normal controls (group YN, *n* = 8). The erectile function test and histological measurements further confirmed the grouping. As illustrated in [**Figure 1**](#F1){ref-type="fig"}, the ratios of ICP/MAP decreased obviously in AE group compared with those in both AN and YN groups while the AN and YN groups were similar in this aspect. Accompanied with the functional data, the smooth muscle and endothelium content within the CC of AE group decreased significantly compared with other two groups. Also, the AN and YN groups were similar in these aspects.

![The erectile function and penile histology of three experimental groups. (a) Representative ICP recording of each experimental group. The blue bar represents 60s electrical stimulation of the CN. The red curve represents ICP values in response to CN stimulation. (**b**) Erectile function parameters (ICP/MAP ratio) of each experimental group. (**c**) Representative images of the smooth muscle (indicated by α-SMA) and endothelium (indicated by vWF) in corpus cavernosum of each group. Percentage of smooth muscle (**d**) and endothelium (**e**) within corpus cavernosum as relative expression as compared with YN group. Original magnifications are ×40 when showed α-SMA, and ×400 when showed vWF. TA: tunica albuginea. \**P* = 0.013, \*\**P* = 0.003, \*\*\**P* = 0.001 compared with other groups.](AJA-18-74-g001){#F1}

### The expression of miR-200a is upregulated while the SIRT1 protein, the levels of eNOS and cGMP are all downregulated in AE group {#sec3-12}

According to the qRT-PCR results, the expression of miR-200a was up-regulated in AE group at a high level with the average threshold criterion CT ≤25.0, and more than two-fold compared with that in both AN and YN groups. On the contrary, the expression of SIRT1 and eNOS and cGMP levels which reflected the endothelial function was all notably downregulated in AE group according to the Western Blotting and ELISA results ([**Figure 2**](#F2){ref-type="fig"}).

![Real-time quantification of miR-200a, Western Blotting results of SIRT1 and ELISA results of eNOS and cGMP levels in three groups. (**a**) The expression levels of miR-200a in each group (analyzed by qRT-PCR). For comparison, the CT value of sno RNA U6, whose mean value in each group was 18.415, 18.635, and 17.909, respectively, was subtracted from the CT value of miR-200a (ΔCT). The y-axis showed the --ΔCT and represents relative miR-200a expression levels. (**b**) The relative expression of miR-200a in each group as compared with YN group. (**c**) Protein expression of SIRT1 in each group as compared with the expression of GAPDH (analyzed by Western Blotting). (**d**) Representative images of the Western Blotting results of SIRT1 and GAPDH. (**e** and **f**) The eNOS and cGMP levels in each group (analyzed by ELISA). The experiments were repeated at least 3 times. \**P* = 0.01, \*\**P* = 0.001, \*\*\**P* = 0.001, \*\*\*\**P* = 0.021, \*\*\*\*\**P* = 0.034, when compared with YN and AN groups. ^\#^*P* = 0.038 compared with YN group.](AJA-18-74-g002){#F2}

### Upregulated miR-200a in CECs results in the downregulation of SIRT1 protein and eNOS and cGMP levels in vitro {#sec3-13}

To study whether up-regulation of miR-200a in the CECs of aged rats with normal erectile function could lead to the downregulation of SIRT1 protein and eNOS and cGMP levels, the CECs from the CCs of group AN were collected, cultured and grouped. The grouping of CECs included CECs from AN group (group E-AN), CECs from AN group transfected with mimics N.C. (group E-AN + NC), CECs from AN group transfected with miR-200a mimics (group E-AN + M). After transfection with miR-200a mimics, the expression of miR-200a was upregulated (*P* = 0.015) and the expression of SIRT1 and eNOS and cGMP levels were all downregulated (*P* = 0.012, 0.004, and 0.024). These regulated relationships manifested that the up-regulation of miR-200a could partially contribute to the decrease of the erectile function of aged rats via SIRT1 inhibition and the *eNOS/NO/PKG* pathway. Meanwhile, there were no significant differences in the expression of miR-200a, SIRT1, eNOS and cGMP levels between the E-AN and E-AN + NC groups ([**Figure 3**](#F3){ref-type="fig"}).

![Alteration of miR-200a, SIRT1, eNOS and cGMP in different cellular groups *in vitro*. (**a**) The expression levels of miR-200a in each group (analyzed by qRT-PCR). The CT value of sno RNA U6, whose mean value in each group was 18.321, 18.346, and 17.849 respectively, was subtracted from the CT value of miR-200a (ΔCT). The y-axis showed the −ΔCT and represents relative miR-200a expression levels. (**b**) Protein expression of SIRT1 in each group as compared with the expression of GAPDH (analyzed by Western Blotting). (**c**) Representative images of the Western Blotting results of SIRT1 and GAPDH. (**d** and **e**) The eNOS and cGMP levels in each group (analyzed by ELISA). The experiments were repeated at least 3 times. \**P* = 0.015, \*\**P* = 0.012, \*\*\**P* = 0.004, \*\*\*\**P* = 0.024, when compared with E-AN and E-AN + NC groups.](AJA-18-74-g003){#F3}

DISCUSSION {#sec1-4}
==========

The genesis and development of A-ED are based on the functional change accomplished with aging. A-ED could be aggravated by exposure to a series of exogenous factors in different degrees or by experiencing several relative systemic diseases such as cardiovascular diseases and diabetes mellitus. Several factors including accelerated aging of the internal pudendal artery, endothelial dysfunction, smooth muscle decrease, deposition of collagen fibers, androgen deficiency, have been demonstrated to be pathophysiological characters of A-ED.[@ref9][@ref30] Also, many signaling pathways and a large amount of related molecules are speculated to be involved in the development of A-ED.[@ref12][@ref31]

MiRNAs could modulate a variety of pathophysiological processes via network regulation to different signaling pathways and molecules. A large number of A-ED related genes, such as *IGF*1, *TGFB*2, *END*1, *CAV*1, *SIRT*1, *BDNF*, have been demonstrated to be regulated by miRNAs.[@ref13][@ref14][@ref15][@ref32][@ref33][@ref34] Based on these findings, our group has explored the miRNAs profiling in aged rats with ED. As a result, four miRNAs were identified as upregulated, and were predicted mainly to regulate *eNOS/NO/PKG* and *PGE*1*/PKA* pathways, which have been considered to be important pathways in the physiology of normal erection. Therefore, it\'s reasonable to speculate that miRNAs might play a crucial role in the development of A-ED.

As one of the predicted miRNAs, miR-200a might be involved in the underlying mechanisms of A-ED through regulating SIRT1 expression and influencing the *eNOS/NO/PKG* pathway function consequently. MiR-200a belongs to the miR-200 family that is an important regulator of tumor progression and metastasis.[@ref35] Much of its predicted and identified targets had been reported, such as *ZEB*1 and *SIP*1.[@ref36] Its targets could constitute networks to participate into different pathophysiological processes via coordinated effects on many pathways, such as Rho-ROCK signaling, MMP activity, and focal adhesions, and thus could also involve in maintaining physiological homeostasis in the vascular system.[@ref37] Interestingly, one study about the function of miR-200a in regulating the epithelial to mesenchymal transition-like transformation manifested that miR-200a could regulate SIRT1.[@ref22] In this study, the researchers established the regulated relationship between the miR-200a and SIRT1 according to the results of luciferase reporter assays. And the 7-mer exact seed at the SIRT1 3'- UTR as a miR-200a target was consistent with our previous study predicted via bioinformatic analysis ([**Figure 4**](#F4){ref-type="fig"}). SIRT1 is a highly conserved nicotinamide adenine dinucleotide (NAD)+-dependent protein deacetylase.[@ref17] It has been highlighted for its importance in several pathophysiological processes of a living organism, particularly in aging, and has been increasingly referenced as a longevity gene.[@ref17][@ref18][@ref22] SIRT1 can also act as a significant protein in maintaining erectile function in the penis. Research has pointed out that SIRT1 could regulate the endothelial homeostasis,[@ref38][@ref39] up-regulate the eNOS activity, increase the NO production, and promote the endothelium-dependent relaxation.[@ref19][@ref20][@ref21] In our previous studies, we also found that the elevation of SIRT1 expression in penile tissue of diabetic ED rats could ameliorate erectile potency and probably ameliorate the endothelial function through suppressing apoptosis and oxidative stress.[@ref14] Based on a combination of these findings, we hypothesized that miR-200a might be involved in the mechanism of A-ED via regulating the expression of SIRT1, and the most probable target tissue might be endothelial cells.

![Predicted target region on the 3'UTR of SIRT1 as well as the seed sequence of miR-200a by the bioinformatic analysis (TargetScan 6.2, [www. targetscan.org](www.targetscan.org)).](AJA-18-74-g004){#F4}

Our *in vivo* data showed that the expression of miR-200a was upregulated (*P* = 0.01) at a high level while the expression of SIRT1 and eNOS and cGMP were all downregulated (*P* = 0.001, 0.021, and 0.034) in the CCs from the aged rats with ED. This is consistent with our previous results that miR-200a could influence *eNOS/NO/PKG* pathway through regulating SIRT1, suggesting the protential role of miR-200a in the pathophysiology of A-ED. To further validate our hypothesis, we designed an *in vitro* study using endothelial cells isolated form rat CC. Accordingly, the expression of SIRT1 in the CECs reduced (*P* = 0.012) after transfection of miR-200a mimics. As the same binded site reported by other reseachers,[@ref22] we didn't conduct the luciferase reporter assays repeatedly to identify the regulated relationship between the miR-200a and SIRT1. As two main molecules of the *eNOS/NO/PKG* pathway, the levels of eNOS and cGMP were both consistent with the expression of SIRT1 in different groups, which were similar to the results of many previous researches about the SIRT1 influencing the endothelial function,[@ref14][@ref19][@ref20][@ref21][@ref38][@ref39] and could also verify that the miR-200a could regulate SIRT1, and mainly influence the eNOS/NO/PKG pathway to contribute to the pathological processes of A-ED.

The main limitation of this study was that, to avoid the degradation of the exogenous RNAs, we only conducted the experiments of transfection *in vitro*, which could only partially represent the situation *in vivo*. Thus, further experiments *in vivo* are needed.

CONCLUSIONS {#sec1-5}
===========

Based on the results of our previous study, we further investigate the relationship between the miR-200a and SIRT1 in the A-ED using a rodent animal model. As a result, we verify that up-regulation of miR-200a could participate in the mechanism of A-ED, to some extent, via SIRT1 inhibition, and mainly attenuate endothelial function via influencing the *eNOS/NO/PKG* pathway. The results of this work could provide new perspectives for the basic researches in the study of A-ED despite lots of further *in vivo* experiments are still needed.
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